Orion Pharma Limited (DSE: ORIONPHARM)

Orion Pharma Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Cash & Equivalents	205.84	130.11	106.13	414.99	1,034	92.19
Short-Term Investments	45.04	38.68	31.83	23.62	19.58	12.03
Cash & Short-Term Investments	250.87	168.79	137.97	438.61	1,054	104.22
Cash Growth	-38.80%	22.34%	-68.54%	-58.38%	911.13%	-79.75%
Accounts Receivable	3,304	5,584	6,796	3,943	2,662	1,700
Other Receivables	9,160	9,811	8,109	8,458	8,987	8,408
Receivables	12,464	15,395	14,905	12,401	11,649	10,108
Inventory	1,718	1,614	1,660	1,411	1,278	918.05
Prepaid Expenses	15.4	15.75	26.19	43.84	44.52	3.15
Other Current Assets	1,741	1,882	2,026	1,928	3,722	1,142
Total Current Assets	16,190	19,076	18,755	16,223	17,747	12,276
Property, Plant & Equipment	27,900	26,424	23,009	19,856	16,633	16,307
Long-Term Investments	8,230	7,440	6,343	6,254	2,462	2,408
Other Long-Term Assets	-	-	-	-	-0	-
Total Assets	52,320	52,940	48,107	42,333	36,841	30,990
Accounts Payable	3,995	6,259	7,301	4,231	2,619	2,008
Accrued Expenses	313.2	270.03	265.44	232.48	225.55	289.43
Short-Term Debt	1,828	547.82	563.9	564.32	566	565.28
Current Portion of Long-Term Debt	447.07	490.5	387.47	274.33	201.88	256.38
Current Portion of Leases	15.3	23.91	31.66	36.42	38.35	15.42
Current Income Taxes Payable	442.65	435.26	398.62	262.75	197.86	188.62
Other Current Liabilities	1,650	1,444	488.23	406.06	599.16	768.17
Total Current Liabilities	8,691	9,470	9,437	6,008	4,447	4,091
Long-Term Debt	20,042	20,808	17,601	15,930	12,871	7,856
Long-Term Leases	12.61	26.35	35.27	39.9	46.91	26.57
Long-Term Deferred Tax Liabilities	139.99	157.7	122.25	138.28	142.61	98.23
Other Long-Term Liabilities	143.41	143.41	143.41	143.41	143.41	143.41
Total Liabilities	29,029	30,606	27,338	22,259	17,651	12,241
Common Stock	2,340	2,340	2,340	2,340	2,340	2,340
Additional Paid-In Capital	8,017	8,017	8,017	8,017	8,017	8,017
Retained Earnings	7,564	7,400	6,978	6,401	5,670	5,329
Comprensive Income & Other	3,844	3,067	1,978	1,905	1,937	1,909
Total Common Equity	21,765	20,824	19,313	18,663	17,964	17,594
Minority Interest	1,526	1,510	1,456	1,412	1,226	1,155
Shareholders' Equity	23,291	22,334	20,769	20,074	19,190	18,749
Total Liabilities & Equity	52,320	52,940	48,107	42,333	36,841	30,990
Total Debt	22,345	21,897	18,619	16,844	13,724	8,720
Net Cash (Debt)	-22,069	-21,700	-18,446	-16,377	-12,647	-8,581
Net Cash Per Share	-94.31	-92.74	-78.83	-69.99	-54.05	-36.67
Filing Date Shares Outstanding	234	234	234	234	234	234
Total Common Shares Outstanding	234	234	234	234	234	234
Working Capital	7,499	9,606	9,318	10,216	13,299	8,185
Book Value Per Share	93.01	88.99	82.53	79.76	76.77	75.19
Tangible Book Value	21,765	20,824	19,313	18,663	17,964	17,594
Tangible Book Value Per Share	93.01	88.99	82.53	79.76	76.77	75.19

Source: S&P Capital IQ. Standard template. Financial Sources.